Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03088384 · ClinicalTrials.gov registry record

Ketamine Infusion Therapy for PTSD in Combat Veterans

A clinical trial of Stress Disorders, Post-Traumatic, sponsored by Klarisana Physician Services P.

Completed
Registry status
30
Enrollment target
1
Study location

NCT03088384 is a study of Stress Disorders, Post-Traumatic that has completed, run by Klarisana Physician Services P. The registered enrollment target is 30 participants, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03088384, a study of Stress Disorders, Post-Traumatic, has completed, sponsored by Klarisana Physician Services P.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Klarisana is conducting an observational study in San Antonio, Texas to see if there are tangible improvements in the symptoms of post traumatic stress disorder (PTSD) in combat veterans after receiving a series of six low-dose outpatient infusions of ketamine.

Interventions

  • DRUG Ketamine

Study Locations (1)

Texas

  • Klarisana - San Antonio

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-11-28
Est. Completion 2018-09-29

Sponsor

Klarisana Physician Services P

1 total trials

What the Registry Record Tells You About NCT03088384

The ClinicalTrials.gov registry entry for NCT03088384 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The listed sponsor is Klarisana Physician Services P, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.

NCT03088384 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03088384 about?

NCT03088384 is a clinical study titled "Ketamine Infusion Therapy for PTSD in Combat Veterans". Klarisana is conducting an observational study in San Antonio, Texas to see if there are tangible improvements in the symptoms of post traumatic stress disorder (PTSD) in combat veterans after receiving a series of six low-dose outpatient infusions of ketamine.

What is the current status of trial NCT03088384?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-11-28. Estimated completion is 2018-09-29.

What conditions does trial NCT03088384 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT03088384?

The interventions under investigation include: Ketamine (DRUG).

Who is sponsoring clinical trial NCT03088384?

This trial is sponsored by Klarisana Physician Services P, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03088384 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.